I am sure that I was not alone to conclude after the 2018 Respiratory Drug Delivery Conference that the most profoundly important session was “Exploring the Benefits of Smart Inhalers on Public Health.” And I immediately thought about the ambitions we had at Aradigm Corporation for our SmartMist device – the first “electronic inhaler.” Smartmist was really smart: … [Read more...] about Igor Gonda: Cloud medicine is not just a pie in the sky for OINDPs
Features
Highlights from RDD 2018
Approximately 550 OINDP specialists attended RDD 2018 in Tucson, Arizona, where much of the interest centered around regulatory issues, especially in light of the FDA's recent release of a revised draft guidance on MDI and DPI quality considerations. The RDD organizers capitalized on the release, adding a late breaking presentation by the FDA's Rik Lostritto on … [Read more...] about Highlights from RDD 2018
Copley Scientific’s Mark Copley answers questions about USP Chapter <1602>
Copley Scientific CEO Mark Copley discusses the recently published USP Chapter <1602> for testing "Spacers & Valved Holding Chambers Used with Inhalation Aerosols" Q: What does this new USP Chapter cover? A: Chapter <1602>, published by the United States Pharmacopeia (USP) in 2017, defines standardized methods for characterizing the in vitro … [Read more...] about Copley Scientific’s Mark Copley answers questions about USP Chapter <1602>
RDD 2018 set to explore hot topics in Tucson
The upcoming RDD 2018 meeting, which will take place April 22-26 in Tucson, AZ, features a program designed to address many of the most pressing questions for OINDP developers today, along with extensive poster and technology exhibitions and a week full of networking opportunities. The RDD 2018 program sessions include: • Frontiers in Lung Biology • Exploring the … [Read more...] about RDD 2018 set to explore hot topics in Tucson
FDA workshop offers insights on OINDP development and BE assessment
By Lei Zhang, PhD, Deputy Director, Office of Research and Standards The FDA’s Center for Drug Evaluation and Research, Office of Generic Drugs (OGD), Office of Research and Standards, Division of Therapeutic Performance has made great strides in new approaches that demonstrate therapeutic equivalence for locally-acting orally-inhaled and nasal drug products … [Read more...] about FDA workshop offers insights on OINDP development and BE assessment
DDL 2017 in review
DDL 2017 drew 750 delegates, a record number, to the Edinburgh International Conference Centre. Topics that received sustained attention over the course of the 3-day meeting included the use of modeling techniques, development of inhaled antibiotics for diseases such as tuberculosis, the lessons of e-cigarettes, and the use of acoustics for inhaler monitoring and … [Read more...] about DDL 2017 in review
Recent advances in inhalation science will be featured at DDL 2017
The 700-plus OINDP specialists expected to convene at the Edinburgh International Conference Centre December 6-8 for this year's Drug Delivery to the Lungs (DDL) meeting will notice a few small changes designed to further the meeting's mission of encouraging inhalation research and to accommodate the growing numbers of delegates and exhibitors, organizers say. One … [Read more...] about Recent advances in inhalation science will be featured at DDL 2017
21st ISAM Congress focused on emerging trends
The 21st Congress of the International Society for Aerosols in Medicine (ISAM), held in Santa Fe, New Mexico June 3-7, 2017 featured presentations and posters covering recent advances in a wide range of topics related to aerosol drug delivery, including novel methods of modeling, trends in device design, and new therapies, and several new devices were on display in … [Read more...] about 21st ISAM Congress focused on emerging trends
RDD Europe 2017 focused on new technology
RDD Europe 2017 which took place April 25-28, 2017 at the Palais des Congrès in Antibes, France, drew almost 500 attendees from 32 countries, the largest RDD Europe meeting to date, organizers said. Throughout the course of the program and exhibition, the focus was on new technology, especially in the form of connected devices, with a number of presenters also … [Read more...] about RDD Europe 2017 focused on new technology
RDD Europe returns to Antibes
For RDD Europe 2017, to be held April 25-28, 2017 at the Palais des Congrès in Antibes, France, organizers RDD Online and Aptar Pharma expect approximately 450 OINDP experts to attend the 3-day conference. Two years ago, the 10th anniversary edition of RDD Europe, which was also held in Antibes, attracted 440 delegates from 31 countries. RDD Online's Richard Dalby … [Read more...] about RDD Europe returns to Antibes